The New Drug Application (NDA) includes data from the Phase III studies OASIS 1, 2 and 3 - showing elinzanetant significantly reduced the frequency and severity of moderate to severe vasomotor symptoms over 12 weeks compared to placebo
BAV has revolutionized the animal vaccination industry with its ground-breaking delivery methods that prioritize quality, safety, and efficacy
Decision on EU marketing authorisation for this population expected by September 2024
Report highlights significant improvements in adolescent well-being in India
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
The pooled prevalence of GERD in the Indian population is 15.6 %
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
Dyslipidemia is a critical risk factor for cardiovascular diseases
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Subscribe To Our Newsletter & Stay Updated
